Nisha Rao

3PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 23, 2026
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

|Mar 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.

Ronan J Kelly, Blair V Landon, Ali H Zaidi

|Nov 08, 2023
Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.

Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink

Pageof 1

Frequent Collaborators

3 joint publications

Valsamo Anagnostou

3 joint publications

Vincent K Lam

2 joint publications

Joseph C Murray

2 joint publications

Christine L Hann